Co-infection with influenza-associated acute respiratory distress syndrome requiring extracorporeal membrane oxygenation

International Journal of Antimicrobial Agents

Volumn 51, Issue 3, 2018, Pages 427-433

  Rozencwajg, Sacha ^a,b   Bréchot, Nicolas ^a   Schmidt, Matthieu ^a,b   Hékimian, Guillaume ^a   Lebreton, Guillaume ^a   Besset, Sébastien ^a   Franchineau, Guillaume ^a   Nieszkowska, Ania ^a   Leprince, Pascal ^a   Combes, Alain ^a,b   Luyt, Charles Edouard ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Acute respiratory distress syndrome; Bacterial and or fungal co infection; Extracorporeal membrane oxygenation; Influenza; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HOSPITAL MORTALITY; HUMAN; INFLUENZA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STAPHYLOCOCCUS INFECTION; COMPLICATION; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; PREVALENCE; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS;

VIRULENCE FACTOR;

ADULT; COINFECTION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; VIRULENCE FACTORS;

EID: 85043365923     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2017.11.005     Document Type: Article

References (31)

1. Brodie, D., Bacchetta, M., Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med 365 (2011), 1905–1914.
2. Extracorporeal Life Support Organization (ELSO), Guidelines for adult respiratory failure. 2013, ELSO Available from: http://www.elso.org/Portals/0/IGD/Archive/FileManager/989d4d4d14cusersshyerdocumentselsoguidelinesforadultrespiratoryfailure1.3.pdf. (Accessed 10 July 2015)
3. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies, A., Jones, D., Bailey, M., Beca, J., Bellomo, R., et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302 (2009), 1888–1895.
4. Hodgson, C.L., Hayes, K., Everard, T., Nichol, A., Davies, A.R., Bailey, M.J., et al. Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia. Crit Care, 16, 2012, R202.
5. Luyt, C.-E., Combes, A., Becquemin, M.-H., Beigelman-Aubry, C., Hatem, S., Brun, A.-L., et al. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest 142 (2012), 583–592.
6. Schmidt, M., Zogheib, E., Rozé, H., Repesse, X., Lebreton, G., Luyt, C.-E., et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 39 (2013), 1704–1713.
7. Schmidt, M., Bailey, M., Sheldrake, J., Hodgson, C., Aubron, C., Rycus, P.T., et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 189 (2014), 1374–1382.
8. Klein, E.Y., Monteforte, B., Gupta, A., Jiang, W., May, L., Hsieh, Y.-H., et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses 10 (2016), 394–403.
9. Martin-Loeches, I., J Schultz, M., Vincent, J.-L., Alvarez-Lerma, F., Bos, L.D., Solé-Violán, J., et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med 43 (2017), 48–58.
10. ARDS Definition Task Force, Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 307 (2012), 2526–2533.
11. Extracorporeal Life Support Organization (ELSO), H1N1 specific supplements to the ELSO general guidelines. 2009, ELSO Available from: https://www.elso.org/Portals/0/Files/elso%20h1n1%20specific%20guidelines.pdf. (Accessed 10 July 2015)
12. Luyt, C.-E., Bréchot, N., Demondion, P., Jovanovic, T., Hekimian, G., Lebreton, G., et al. Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med 42 (2016), 897–907.
13. de Chambrun, M.P., Bréchot, N., Lebreton, G., Schmidt, M., Hekimian, G., Demondion, P., et al. Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest. Intensive Care Med 42 (2016), 1999–2007 Erratum in: Intensive Care Med 2017;43:1940.
14. Dangers, L., Bréchot, N., Schmidt, M., Lebreton, G., Hekimian, G., Nieszkowska, A., et al. Extracorporeal membrane oxygenation for acute decompensated heart failure. Crit Care Med 45 (2017), 1359–1366.
15. Shah, N.S., Greenberg, J.A., McNulty, M.C., Gregg, K.S., Riddell, J. IV, Mangino, J.E., et al. Bacterial and viral co-infections complicating severe influenza: incidence and impact among 507 U.S. patients, 2013–14. J Clin Virol 80 (2016), 12–19.
16. Morens, D.M., Taubenberger, J.K., Fauci, A.S., Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198 (2008), 962–970.
17. Rozencwajg, S., Pilcher, D., Combes, A., Schmidt, M., Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with extracorporeal membrane oxygenation. Crit Care, 20, 2016, 392.
18. Bellani, G., Laffey, J.G., Pham, T., Fan, E., Brochard, L., Esteban, A., et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315 (2016), 788–800.
19. Forrest, P., Ratchford, J., Burns, B., Herkes, R., Jackson, A., Plunkett, B., et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med 37 (2011), 824–830.
20. Roch, A., Hraiech, S., Masson, E., Grisoli, D., Forel, J.-M., Boucekine, M., et al. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med 40 (2014), 74–83.
21. Schmidt, M., Combes, A., Influence of ventilatory strategy on the PRESERVE mortality risk score: response to Camporota. Intensive Care Med, 40, 2014, 916.
22. Cuquemelle, E., Soulis, F., Villers, D., Roche-Campo, F., Ara Somohano, C., Fartoukh, M., et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 37 (2011), 796–800.
23. Rice, T.W., Rubinson, L., Uyeki, T.M., Vaughn, F.L., John, B.B., Miller, R.R. III, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 40 (2012), 1487–1498.
24. Blyth, C.C., Webb, S.A.R., Kok, J., Dwyer, D.E., van Hal, S.J., Foo, H., et al. The impact of bacterial and viral co-infection in severe influenza. Influenza Other Respir Viruses 7 (2013), 168–176.
25. Loffler, B., Niemann, S., Ehrhardt, C., Horn, D., Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. Expert Rev Anti Infect Ther 11 (2013), 1041–1051.
26. Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., et al. Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359 (2002), 753–759.
27. Peyrani, P., Allen, M., Wiemken, T.L., Haque, N.Z., Zervos, M.J., Ford, K.D., et al. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton–Valentine leukocidin gene. Clin Infect Dis 53 (2011), 766–771.
28. Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., et al. Guidelines for the management of adult lower respiratory tract infections—full version. Clin Microbiol Infect 17:Suppl. 6 (2011), E1–59.
29. Wauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 38 (2012), 1761–1768.
30. van de Veerdonk, F.L., Kolwijck, E., Lestrade, P.P.A., Hodiamont, C.J., Rijnders, B.J.A., van Paassen, J., et al. Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med, 2017, 10.1164/rccm.201612-2540LE Epub ahead of print.
31. Combes, A., Brodie, D., Bartlett, R., Brochard, L., Brower, R., Conrad, S., et al. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 190 (2014), 488–496.